Literature DB >> 15704316

Minimum internal diameter of the greater saphenous vein is an important determinant of successful femorodistal bypass grafting that is independent of the quality of the runoff.

Yoshiyori Ishii1, James A Gossage, Renato Dourado, Tarun Sabharwal, Kevin G Burnand.   

Abstract

The greater saphenous vein is assessed as part of the workup for femorodistal bypass surgery in our unit. The aim of this study was to determine whether the minimum internal diameter (MID) of the vein predicted graft patency and limb salvage in femorodistal bypass surgery, independently of the quality of the runoff. A consecutive series of 67 infrainguinal vein bypass grafts were performed on 62 patients with critical lower limb ischemia. All were followed for at least 1 year. The MID of the greater saphenous vein was calculated from preoperative saphenograms, and all of the arteriograms were scored for their runoff using an ad hoc method approved by the Society for Vascular Surgery. The cumulative patency of all vein grafts at 3 years was 59 +/- 7% (SE), and the limb salvage was 85 +/- 5%. All femoropopliteal bypass grafts were patent at 3 years if the MID of the vein was greater than 3.0 mm. The crural bypass patency was 66 +/- 12% for an MID greater than 3.0 mm and only 27 +/- 12% for an MID less than 3.0 mm. Every extra point on the runoff score increased the hazard of bypass failure by 16% (95% CI 1.0-34; p < .05). Vein diameter and runoff score were independent of one another (r2 = -.106). The MID of the greater saphenous vein is a major determinant of outcome in infrainguinal vein bypass surgery independent of the arterial runoff.

Entities:  

Mesh:

Year:  2004        PMID: 15704316     DOI: 10.1258/rsmvasc.12.4.225

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  5 in total

1.  Perioperative use of eicosapentaenoic acid and patency of infrainguinal vein bypass: A retrospective chart review.

Authors:  Shinsuke Mii; Terutoshi Yamaoka; Daihiko Eguchi; Jin Okazaki; Kiyoshi Tanaka
Journal:  Curr Ther Res Clin Exp       Date:  2007-05

2.  Examination of race and infrainguinal bypass conduit use in the Society for Vascular Surgery Vascular Quality Initiative.

Authors:  Luke Stewart; Benjamin J Pearce; Adam W Beck; Emily L Spangler
Journal:  Vascular       Date:  2020-05-25       Impact factor: 1.285

3.  Anti-phosphorylcholine IgM, an Anti-inflammatory Mediator, Predicts Peripheral Vein Graft Failure: A Prospective Observational Study.

Authors:  Michael Sobel; Mayumi Yagi; Katherine Moreno; Ted R Kohler; Gale L Tang; Errol S Wijelath; Julieann Marshall; Richard D Kenagy
Journal:  Eur J Vasc Endovasc Surg       Date:  2018-10-19       Impact factor: 7.069

4.  Saphenous vein dilation as an alternative to prosthetic femoral-distal bypass revascularization.

Authors:  Eric J Maldonado; Kaspar Trocha; David J Finlay
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-07-16

Review 5.  Small Diameter Cell-Free Tissue-Engineered Vascular Grafts: Biomaterials and Manufacture Techniques to Reach Suitable Mechanical Properties.

Authors:  María A Rodríguez-Soto; Camilo A Polanía-Sandoval; Andrés M Aragón-Rivera; Daniel Buitrago; María Ayala-Velásquez; Alejandro Velandia-Sánchez; Gabriela Peralta Peluffo; Juan C Cruz; Carolina Muñoz Camargo; Jaime Camacho-Mackenzie; Juan Guillermo Barrera-Carvajal; Juan Carlos Briceño
Journal:  Polymers (Basel)       Date:  2022-08-23       Impact factor: 4.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.